Literature DB >> 8326268

Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

A M Chancellor1, R J Swingler, H Fraser, J A Clarke, C P Warlow.   

Abstract

OBJECTIVES: To determine the accuracy of (1) hospital discharge data and (2) death certificates, coded as motor neuron disease (MND).
DESIGN: Comparison of data from The Scottish Motor Neuron Disease Register (SMNDR) with routinely collected Scottish Hospital In-Patient Statistics (SHIPS) and death certificate coding.
SETTING: Scotland UK. PATIENTS: 1) 379 adults (> 15 years) discharged for the first time from a Scottish hospital in 1989-90 and (2) 281 deaths in the same period assigned to the International Classification of Diseases (ICD)-9, category 335 (MND). MAIN OUTCOME MEASURES: The sensitivity and positive predictive value of a diagnosis of MND as retrieved by (1) the Information and Statistics Division of the Common Services Agency for the Scottish Health Service for morbidity data and (2) the Registrar General's office for mortality data, using the SMNDR as the 'gold standard'.
RESULTS: (1) Thirty per cent of adult patients identified as having MND by SHIPS did not have this disease and 23% of patients with MND did not appear on SHIPS. The sensitivity of a diagnosis of MND, as retrieved by SHIPS, was 84% and the positive predictive value was 70% overall. Miscoding of patients with pseudobulbar palsy caused by cerebrovascular disease was the major source of false positive error. The incidence of adult onset sporadic MND was over estimated by SHIPS by a factor of 1.6. (2) Mortality data were more accurate, with a false negative rate of 6% and a positive predictive value of 90%.
CONCLUSIONS: Coded hospital discharge data are an inaccurate record of a diagnosis of MND and cannot, in their present form, be used as a reliable measure of disease incidence in Scotland. Greater care is required in the preparation of discharge summaries and coding if these data are to be useful for health care planning and epidemiological research. SHIPS is, however, an important source of information to achieve a complete sample of patients with MND. There is also a problematic false positive rate for mortality data but this source more closely approximates true incidence.

Entities:  

Mesh:

Year:  1993        PMID: 8326268      PMCID: PMC1059738          DOI: 10.1136/jech.47.2.116

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  23 in total

1.  Motor neuron disease and polio in Scotland.

Authors:  R J Swingler; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Scottish hospital morbidity data. 1. Errors in diagnostic returns.

Authors:  A R Patel; G Gray; G D Lang; F G Baillie; L Fleming; G M Wilson
Journal:  Health Bull (Edinb)       Date:  1976-07

3.  Changing mortality patterns of motor neuron disease in Japan.

Authors:  K Kondo; T Tsubaki
Journal:  J Neurol Sci       Date:  1977-07       Impact factor: 3.181

4.  Accuracy of Scottish hospital morbidity data.

Authors:  E Lockwood
Journal:  Br J Prev Soc Med       Date:  1971-05

5.  The epidemiology of motor neuron disease in Scotland.

Authors:  S M Holloway; A E Emery
Journal:  Muscle Nerve       Date:  1982-02       Impact factor: 3.217

6.  Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death.

Authors:  M Leone; V Chandra; B S Schoenberg
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

7.  Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study.

Authors:  K Murros; R Fogelholm
Journal:  Acta Neurol Scand       Date:  1983-01       Impact factor: 3.209

8.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

9.  Urgent opportunistic observations: the study of changing, transient and disappearing phenomena of medical interest in disrupted primitive human communities.

Authors:  D C Gajdusek
Journal:  Ciba Found Symp       Date:  1977

10.  Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy.

Authors:  G Rosati; L Pinna; E Granieri; I Aiello; R Tola; V Agnetti; A Pirisi; P de Bastiani
Journal:  Acta Neurol Scand       Date:  1977-03       Impact factor: 3.209

View more
  14 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

2.  Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Freya Kamel; Dale P Sandler; Pär Sparén; Weimin Ye
Journal:  Am J Epidemiol       Date:  2008-03-25       Impact factor: 4.897

3.  Diagnostic validity of hospital discharge codes in the ascertainment of amyotrophic lateral sclerosis.

Authors:  Alvaro Alonso
Journal:  Eur J Epidemiol       Date:  2009-12-19       Impact factor: 8.082

Review 4.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 5.  Recommendations for optimal ICD codes to study neurologic conditions: a systematic review.

Authors:  Christine St Germaine-Smith; Amy Metcalfe; Tamara Pringsheim; Jodie Irene Roberts; Cynthia A Beck; Brenda R Hemmelgarn; Jane McChesney; Hude Quan; Nathalie Jette
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

6.  Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Liselotte Himmerslev; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-06       Impact factor: 4.092

7.  Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.

Authors:  R J Davenport; R J Swingler; A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

8.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

9.  The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital.

Authors:  Federica Edith Pisa; Lorenzo Verriello; Laura Deroma; Daniela Drigo; Paolo Bergonzi; Gian Luigi Gigli; Fabio Barbone
Journal:  Eur J Epidemiol       Date:  2009-08-06       Impact factor: 8.082

10.  Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009.

Authors:  Ryan M Seals; Johnni Hansen; Ole Gredal; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2013-09-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.